The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.

Purpose: Aberrant DNA content has been discussed as a potential prognostic feature in prostate cancer.

Experimental Design: We analyzed the clinical significance of DNA ploidy in combination with prognostic relevant deletions of PTEN and 6q15 in 3,845 prostate cancers.

Result: The DNA status was diploid in 67.